Evidence map›Paper›PMID 28051353›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2017

Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.

Jia-Ru Wei, Xiaofeng Wen, Paul W Bible, Zhiyu Li, Robert B Nussenblatt, Lai Wei

Open access · greenAbstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Pharmaceutical biology · 2023
    Article
  3. Review
  4. Article
  5. Experimental and therapeutic medicine · 2021
    Article
  6. Article
  7. Review
  8. Effects of Co-Administration of Icariin andNeuropsychiatric disease and treatment · 2020
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jia-Ru Wei1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University , Guangzhou, China .
Xiaofeng Wen1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University , Guangzhou, China .
Paul W Bible1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University , Guangzhou, China .
Zhiyu Li3 Laboratory of Immunology, National Eye Institute, National Institutes of Health , Bethesda, Maryland.
Robert B Nussenblatt3 Laboratory of Immunology, National Eye Institute, National Institutes of Health , Bethesda, Maryland.
Lai Wei1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University , Guangzhou, China .
Sun Yat-sen University · CNNational Institutes of Health · USNational Eye Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePanax Notoginseng, a traditional Chinese medicine, is known as an anti-inflammatory herb. However, the molecular mechanism by which it controls helper T cell mediated immune responses is largely unknown.

methodsNaive CD4

resultsWe found that PNS control the proliferation and differentiation of Th17 cells by globally downregulating the expression of inflammatory cytokines and cell cycle genes.

conclusionsThese findings demonstrated that PNS function as an anti-inflammatory agent through directly targeting Th17 cell mediated immune response.

Indexed as

AnimalsBehcet SyndromeCell ProliferationHumansInterleukin-17MiceOligonucleotide Array Sequence AnalysisPanax notoginsengSaponinsT-Lymphocytes, Helper-InducerInterleukin-17SaponinsBehcet's diseaseCD4+ T cellsPanax Notoginseng saponinTh17

Identifiers

PMID28051353
PMCPMC5583554
OpenAlexW2592364610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.